EQUILLIUM INC reports a Return on Equity (ROE) of -32.03%.

What is EQ's dividend yield?

EQUILLIUM INC offers a dividend yield of 0.00%.

What is EQ's Quality Score?

Our AI rates EQ's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy EQ?

Our AI Timing Score for EQ is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does EQ belong to?

EQUILLIUM INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

EQ (NASDAQ) Stock Analysis | EQUILLIUM INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

EQ AI Analysis Summary

Our AI summary for EQ: EQUILLIUM INC (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -32.03%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

EQ

EQUILLIUM INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 89

USD 2.20

-0.12 (-5.17%) Day Change

Watchlist Portfolio Compare Chart

0.01

D/E

-32.0%

ROE

-30.2%

ROA

0.00%

Div Yield

EQUILLIUM INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 2.20 Price -0.12 (-5.17%) Day Change	NEWS SCORE: 89

EQ, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...

Quality Factors

42%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	89
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	2.20
PBV / Sector	2.47 / 5.20
Earning Per Share	-0.29

PE / Sector	N/A / 19.97
PEG or PE/Growth / Sector	N/A / 1.22
Average 1M Daily Value	1.94 M GREAT
Average 1W Daily Value	1.26 M GREAT

Timing Factors

14%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 98.71
NPM Average (%) / Sector	-4,420.49 / -1,721.76
NPM Change Average (%) / Sector	21,857.95 / 5,211.62 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-30.21 / 27.02
ROA Average (%) / Sector	-47.59 / -368.17
ROA Change Average (%) / Sector	4.62 / 5,404.12
ROE (%) / Sector	-32.03 / 3.47
ROE Average (%) / Sector	-81.44 / 6.51
ROE Change Average (%) / Sector	-18.04 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

Registration Details

Analyze Date	2026-08-01 07:59:47
Symbol	EQ
Name	EQUILLIUM INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	63.23 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	146.69 / 9,903.94

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 2223 Avenida De La Playa, La Jolla, CA, United States, 92037

Phone: 858 240 1200

Website: https://www.equilliumbio.com

Sector: Healthcare >> Biotechnology

Description: Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of celiac diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.